Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
Despite advancements in the current standard of care, cardiovascular diseases continue to hold the top spot as the leading cause of mortality worldwide. The development of atherosclerosis is the most common culprit behind ailments such as myocardial infarction, stroke, and peripheral vascular diseas...
Main Authors: | Mauro Vaccarezza, Francesco Maria Galassi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/7/2519 |
Similar Items
-
Statin Prescription Patterns and Associations with Subclinical Inflammation
by: Preetham Kadappu, et al.
Published: (2022-08-01) -
Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy
by: Nunzio Montelione, et al.
Published: (2023-03-01) -
CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01) -
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
by: Enrica Rossini, et al.
Published: (2022-08-01) -
Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population
by: Ginner Odorico Rizo Rivera, et al.
Published: (2023-09-01)